BPA Call 36C25919A0043-36C25922N0056
- Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...
- Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...
- Luminex Corp has been awarded a Blanket Purchase Agreement (BPA) call valued at $92,743.36 for luminex reagents under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract, executed on August 1, 2024, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order from Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs' regional network serving veterans across multiple northeastern states....
- The Department of Veterans Affairs (VA) awarded a $31,305.20 firm-fixed price purchase order contract to Luminex Corp for Luminex Verigene Reagents to be delivered to the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia. This contract was awarded as an unrestricted competition through RFQ 36C24523Q1172. The contract has a period of performance through September 30, 2024. Luminex Corp is a manufacturer of biological testing technologies and has a history of providing products and...
- This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
- This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
- The Department of Veterans Affairs awarded a Blanket Purchase Agreement (BPA) call order to Luminex Corp, a manufacturer of biological testing technologies, for REAGENTS AND CONSUMABLES FOR COVID19 TESTING. The $26,937 firm fixed-price contract was awarded on February 1, 2022 through the GSA Schedule for In vitro Diagnostics, Reagents, and Test Kits. The award has an ultimate completion date of July 31, 2022 and does not include a set-aside designation. As a prime contractor, Luminex provides...
- This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...
- Luminex Corporation was awarded a $54,542.40 firm fixed price blanket purchase agreement call against the General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The contract calls for the delivery of reagents and consumables for Luminex multiplexing technology to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, with performance taking place in North Providence, Rhode Island. No...
- This is a $30,000.00 firm fixed price delivery order awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Luminex Corp, a manufacturer of biological testing technologies. The order is for the VERIGENE SP GOLD AGREEMENT, which provides Luminex's proprietary multiplexing systems, assay kits, reagents, and related diagnostic testing products to support the VA's clinical testing programs. The contract vehicle is a Multiple Award...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79719D0244-36C25919A0043Blanket Purchase Agreement
- 36C25919A0043-36C25922N0056BPA Call
Luminex Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of Veterans Affairs (VA) to provide VERIGENE brand reagents and supplies for the Rocky Mountain Regional VA Medical Center. The contract has a potential value of $0.00 and a completion date of September 30th, 2022. It was awarded on October 1st, 2021 under the VA's GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, with place of performance in Austin, Texas. No set-aside designation was used. The contract will deliver reagents and supplies to support diagnostic testing services at the Rocky Mountain Regional VA Medical Center as part of the VA's efforts to provide healthcare services to eligible veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($92k) | 1/24/23 | |
| Not listed | Not listed | $92.0k | 10/1/21 |